Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Silence Therapeutics nets important patent in Europe
January 22, 2018 Off

Silence Therapeutics nets important patent in Europe

By Dino Mustafić

Silence Therapeutics strengthen the protection for its innovative chemical modification technology in Europe, as the European Patent Office granted it…

Celgene Corporation to acquire Juno Therapeutics, building global leadership in cellular immunotherapy
January 22, 2018 Off

Celgene Corporation to acquire Juno Therapeutics, building global leadership in cellular immunotherapy

By Dino Mustafić

Celgene Corporation will acquire Juno Therapeutics, it has been announced as the two companies have signed a merger agreement.

European Commission OK’s BMS’s Yervoy for children with unresectable or metastatic melanoma
January 22, 2018 Off

European Commission OK’s BMS’s Yervoy for children with unresectable or metastatic melanoma

By Dino Mustafić

In addition to today’s news about Yervoy in combination with Opdivo , Bristol-Myers Squibb said today that the European Commission (EC) has…

January 22, 2018 Off

BMS says Opdivo and Yervoy benefitial for patients with certain metastatic colorectal cancer

By Dino Mustafić

Bristol-Myers Squibb Company today said that new data from a cohort of the phase 2 CheckMate -142 test of the…

Sanofi goes shopping, buys Bioverativ, for $11.6 billion, adds hemophilia and other rare blood disorders specialist to the basket
January 22, 2018 Off

Sanofi goes shopping, buys Bioverativ, for $11.6 billion, adds hemophilia and other rare blood disorders specialist to the basket

By Dino Mustafić

Sanofi will buy Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, for $11,6…

Bavarian Nordic kicks-off cancer candidate trial
January 19, 2018 Off

Bavarian Nordic kicks-off cancer candidate trial

By Dino Mustafić

Bavarian Nordic said Friday that it has kicked off a clinical trial of BN-Brachyury, a novel cancer immunotherapy candidate designed…

AstraZeneca does business in Japan, another approval today, for Fasenra
January 19, 2018 Off

AstraZeneca does business in Japan, another approval today, for Fasenra

By Dino Mustafić

AstraZeneca and its global biologics research and development arm, MedImmune, said on Friday that the Japanese Ministry of Health, Labour…

January 19, 2018 Off

AZ’s Lynparza approved in Japan for the treatment of advanced ovarian cancer

By Dino Mustafić

AstraZeneca and Merck have announced that the Japanese Ministry of Health, Labour and Welfare has approved Lynparza (olaparib) tablets (300mg…

Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars
January 19, 2018 Off

Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars

By Dino Mustafić

Sandoz, a Novartis division and the global leader in biosimilars, today announced a global partnership with Asia’s premier biopharmaceuticals company,…

STADA to early terminate license agreement with Sanofi for head lice lotion Hedrin
January 19, 2018 Off

STADA to early terminate license agreement with Sanofi for head lice lotion Hedrin

By Dino Mustafić

STADA Arzneimittel AG is advancing the internationalization of its OTC brand business. On January 12, 2018, the company reached an…

Posts pagination

Previous 1 … 3,413 3,414 3,415 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine